Wen Gu

3.0k total citations · 1 hit paper
32 papers, 1.5k citations indexed

About

Wen Gu is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Wen Gu has authored 32 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 8 papers in Pulmonary and Respiratory Medicine and 7 papers in Oncology. Recurrent topics in Wen Gu's work include Lung Cancer Treatments and Mutations (4 papers), Colorectal Cancer Treatments and Studies (3 papers) and Lung Cancer Research Studies (3 papers). Wen Gu is often cited by papers focused on Lung Cancer Treatments and Mutations (4 papers), Colorectal Cancer Treatments and Studies (3 papers) and Lung Cancer Research Studies (3 papers). Wen Gu collaborates with scholars based in United States, China and Switzerland. Wen Gu's co-authors include Margaret S. Pepe, Holly Janes, Ralph J. DeBerardinis, Thomas P. Mathews, Zhiyu Zhao, Sean J. Morrison, M. S. Pepe, Stacy Y. Kasitinon, Alpaslan Tasdogan and William E. Lowry and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Clinical Investigation.

In The Last Decade

Wen Gu

30 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Metabolic heterogeneity confers differences in melanoma metastatic potential

2019 355 citations Alpaslan Tasdogan, Brandon Faubert et al. Nature profile →

Peers

Countries citing papers authored by Wen Gu

Since Specialization

Citations

This map shows the geographic impact of Wen Gu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wen Gu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wen Gu more than expected).

Fields of papers citing papers by Wen Gu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wen Gu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wen Gu. The network helps show where Wen Gu may publish in the future.

Co-authorship network of co-authors of Wen Gu

This figure shows the co-authorship network connecting the top 25 collaborators of Wen Gu. A scholar is included among the top collaborators of Wen Gu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wen Gu. Wen Gu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Somatic mutations in TBX3 promote hepatic clonal expansion by accelerating VLDL secretion 2025 ·Journal of Clinical Investigation ·Giuseppe Mannino, (unknown), Min Zhu, Zixi Wang, Xun Wang, Boyuan Li, (unknown), Thomas P. Mathews, Lauren G. Zacharias, Wen Gu, Purva Gopal, Natalia Brzozowska, (unknown), Matthew Hoare, Glen Liszczak, Hao Zhu	0
2	Targeting POLRMT by IMT1 inhibits colorectal cancer cell growth 2024 ·Cell Death and Disease ·Hao Wang, Yuxin Liu, (unknown), Yongyou Wu, Wen Gu, Guojian Yin	1
3	Jianghu decoction and its active component polydatin inhibit inflammation and fibrotic lesions in the lungs of ILD mice via the AMPK signaling pathway 2023 ·Journal of Ethnopharmacology ·(unknown), (unknown), Wen Gu, Yang Jiao, (unknown), Hui Liu, Wei‐Guo Ma, Honghong Zhang, (unknown), Dali Wang, Yanan Wang, Chunguo Wang, (unknown)	2
4	L-2-hydroxyglutaric aciduria – review of literature and case series 2023 ·Annals of Medicine and Surgery ·Sibtain Ahmed, (unknown), Ralph J. DeBerardinis, Min Ni, Wen Gu, Feng Cai, Hieu Vu, Bushra Afroze	5
5	Aspartate availability limits hematopoietic stem cell function during hematopoietic regeneration 2021 ·Cell stem cell ·Le Qi, Misty S. Martin-Sandoval, (unknown), Wen Gu, Matthias Eckhardt, Thomas P. Mathews, Zhiyu Zhao, Michalis Agathocleous, Sean J. Morrison	51
6	Development of Novel Mitochondrial Pyruvate Carrier Inhibitors to Treat Hair Loss 2021 ·Journal of Medicinal Chemistry ·Xiaoguang Liu, Aimee Flores, (unknown), Wen Gu, (unknown), Heather R. Christofk, William E. Lowry, Michael E. Jung	22
7	Metabolic heterogeneity confers differences in melanoma metastatic potential breakdown → 2019 ·Nature ·Alpaslan Tasdogan, Brandon Faubert, Vijayashree Ramesh, Jessalyn M. Ubellacker, Bo Shen, Ashley Solmonson, Malea M. Murphy, Zhimin Gu, Wen Gu, Misty Martin, Stacy Y. Kasitinon, Travis Vandergriff, Thomas P. Mathews, Zhiyu Zhao, Dirk Schadendorf, Ralph J. DeBerardinis, Sean J. Morrison	355
8	Application of time-dependent modeling for the exposure–efficacy analysis of ceritinib in untreated ALK-rearranged advanced NSCLC patients 2019 ·Cancer Chemotherapy and Pharmacology ·Yvonne Lau, Wen Gu, (unknown), Ying Hong, Xinrui Zhang, Patrick Urban	5
9	Health-related quality of life in Chinese inpatients with lung cancer treated in large general hospitals: across-sectional study 2018 ·BMJ Open ·Wen Gu, Yan‐Min Xu, Bao‐Liang Zhong	25
10	Do cognitive and neuropsychological functioning deficits coincide with hippocampal alteration during first-psychotic episode? 2018 ·CNS Spectrums ·Bashkim Kadriu, Wen Gu, (unknown), Jeffrey M. Levine	1
11	Inosine Monophosphate Dehydrogenase Dependence in a Subset of Small Cell Lung Cancers 2018 ·Cell Metabolism ·Fang Huang, Min Ni, Milind D. Chalishazar, Kenneth E. Huffman, Jiyeon Kim, Ling Cai, Xiaolei Shi, Feng Cai, Lauren G. Zacharias, Abbie S. Ireland, Kailong Li, Wen Gu, Akash Kaushik, Xin Liu, Adi F. Gazdar, Trudy G. Oliver, John D. Minna, Zeping Hu, Ralph J. DeBerardinis	123
12	ASCEND-8: A Randomized Phase 1 Study of Ceritinib, 450 mg or 600 mg, Taken with a Low-Fat Meal versus 750 mg in Fasted State in Patients with Anaplastic Lymphoma Kinase (ALK)-Rearranged Metastatic Non–Small Cell Lung Cancer (NSCLC) 2017 ·Journal of Thoracic Oncology ·Byoung Chul Cho, Dong‐Wan Kim, Alessandra Bearz, Scott A. Laurie, Mark J. McKeage, Gloria Borra, Keunchil Park, Sang-We Kim, Marwan Ghosn, Andrea Ardizzoni, Evaristo Maiello, Alastair Greystoke, Richard Yu, Karen A. Osborne, Wen Gu, Jeffrey W. Scott, Vanessa Q. Passos, Yvonne Lau, Anna Wrona	126
13	Assessment of drug–drug interaction potential between ceritinib and proton pump inhibitors in healthy subjects and in patients with ALK-positive non-small cell lung cancer 2017 ·Cancer Chemotherapy and Pharmacology ·Yvonne Lau, Wen Gu, Tiffany Lin, Kalyanee Viraswami-Appanna, Can Cai, Jeffrey W. Scott, Michael Shi	15
14	Glycolytic Metabolism Plays a Functional Role in Regulating Human Pluripotent Stem Cell State 2016 ·Cell stem cell ·Wen Gu, Xavier Gaeta, Anna Sahakyan, Alanna B. Chan, (unknown), Rachel Kim, Daniel Braas, Kathrin Plath, William E. Lowry, Heather R. Christofk	205
15	Impact of Anti-Drug Antibodies in Preclinical Pharmacokinetic Assessment 2013 ·The AAPS Journal ·Theingi M. Thway, (unknown), (unknown), Vibha Jawa, Wen Gu, Mark Ma	39
16	Model-based strategy for bioanalytical method comparison: Measurement of a soluble ligand as a biomarker 2011 ·Journal of Pharmaceutical and Biomedical Analysis ·Theingi M. Thway, Jin Wang, (unknown), Wen Gu, (unknown), Guy E. Padbury, Mark Ma	3
17	Surgical treatment for early hepatocellular carcinoma: comparison of resection and liver transplantation 2010 ·Journal of Cancer Research and Clinical Oncology ·Jian Zhou, Zheng Wang, Shuang–Jian Qiu, Xiaowu Huang, Jian Sun, Wen Gu, Jia Fan	30
18	Estimating the diagnostic likelihood ratio of a continuous marker 2010 ·Biostatistics ·Wen Gu, M. S. Pepe	17
19	Measures to Summarize and Compare the Predictive Capacity of Markers 2009 ·The International Journal of Biostatistics ·Wen Gu, Margaret S. Pepe	41
20	Estimating the capacity for improvement in risk prediction with a marker 2008 ·Biostatistics ·Wen Gu, M. S. Pepe	38

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact